Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes

Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults

(2020) Lynne Shinto et al.   JOURNAL OF ALZHEIMERS DISEASE

A Synoptic Overview of Neurovascular Interactions in the Foot

(2020) Gayathri Balasubramanian et al.   Frontiers in Endocrinology

Increased expression of soluble epoxide hydrolase in the brain and liver from patients with major psychiatric disorders: A role of brain – liver axis

(2020) Jiancheng Zhang et al.   JOURNAL OF AFFECTIVE DISORDERS

Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia Poststroke

(2020) Michael Ouk et al.   STROKE

Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies

(2020) Kelsey Hildreth et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders

(2019) Kenji Hashimoto   Frontiers in Pharmacology

Astrocytic Epoxyeicosatrienoic Acid Signaling in the Medial Prefrontal Cortex Modulates Depressive-like Behaviors

(2019) Wenchao Xiong et al.   JOURNAL OF NEUROSCIENCE

Liver Soluble Epoxide Hydrolase Regulates Behavioral and Cellular Effects of Chronic Stress

(2019) Xi-He Qin et al.   Cell Reports

WHO-5 and BDI-II are acceptable screening instruments for depression in people with diabetes

(2018) N L Rauwerda et al.   DIABETIC MEDICINE

Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target

(2018) W. Swardfager et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety

(2018) Thomas Larrieu et al.   Frontiers in Physiology

Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment

(2018) Di Yu et al.   Translational Stroke Research

Postprandial effect to decrease soluble epoxide hydrolase activity: roles of insulin and gut microbiota

(2017) Jun Yang et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

A dark side to omega-3 fatty acids

(2017) Keisuke Yanagida et al.   NATURE

Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy

(2017) Jiong Hu et al.   NATURE

Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: An exploratory study

(2017) Marie Hennebelle et al.   PSYCHIATRY RESEARCH

The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities

(2016) Derek M. Erion et al.   BMB Reports

Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress

(2016) Qian Ren et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CYP450-derived oxylipins mediate inflammatory resolution

(2016) Derek W. Gilroy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes

(2016) Jasmine Carter et al.   PSYCHONEUROENDOCRINOLOGY

Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism

(2015) Arthur A. Spector et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa

(2015) P B Shih et al.   MOLECULAR PSYCHIATRY

Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs

(2015) Melissa Gabbs et al.   Advances in Nutrition

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

(2015) Klaus G. Parhofer   Diabetes & Metabolism Journal

The association between diabetes and an episode of depressive symptoms in the 2002 World Health Survey: an analysis of 231 797 individuals from 47 countries

(2013) P. M. C. Mommersteeg et al.   DIABETIC MEDICINE

Anti-inflammatory Effects of ω-3 Polyunsaturated Fatty Acids and Soluble Epoxide Hydrolase Inhibitors in Angiotensin-II–Dependent Hypertension

(2013) Arzu Ulu et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence

(2013) Souhel Najjar et al.   Journal of Neuroinflammation

Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids

(2012) Dmitry Grapov et al.   PLoS One

Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis

(2010) A. Nouwen et al.   DIABETOLOGIA

Quantitative Profiling Method for Oxylipin Metabolome by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry

(2009) Jun Yang et al.   ANALYTICAL CHEMISTRY